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In this issue of Cell, Yang et al. (2006b) show that PDGF, a growth factor that induces the 
transition of epithelial cells to mesenchymal cells, stimulates the c-Abl kinase-dependent 
phosphorylation of p68 RNA helicase. Phosphorylated p68 dissociates β-catenin from the 
Axin destruction complex, thereby promoting nuclear β-catenin signaling independent of 
Wnt activation.The epithelial-mesenchymal transi-
tion (EMT) is a developmental proc-
ess during which epithelial cells lose 
polarity, cell-cell contacts, and other 
epithelial characteristics and acquire 
properties (such as increased motil-
ity) that are typical of mesenchymal 
cells. Common EMT features include 
loss of E-cadherin at the plasma 
membrane, increased nuclear β-cat-
enin, gain of vimentin and fibronec-40 Cell 127, October 6, 2006 ©2006 Elsetin expression, and a fibroblastoid 
morphology. EMT is critical for mor-
phogenetic events, including gas-
trulation and organogenesis, and 
is also likely to be involved in proc-
esses such as tissue repair and can-
cer invasion (Thiery and Sleeman 
2006). Many different signaling path-
ways have been implicated in EMT, 
including receptor tyrosine kinases, 
transforming growth factor β (TGFβ), 
Notch, and Wnt (Thiery and Sleeman 
2006). In this issue of Cell, Yang et 
al. (2006b) reveal a new player in the 
EMT network, p68 RNA helicase.
p68 belongs to the DEAD-box 
family of RNA helicases that are con-
served throughout evolution (Rocak 
and Linder 2004). RNA helicases 
including p68 exhibit RNA-depend-
ent ATPase activity that unwinds 
RNA structures or dissociates RNA-
protein interactions, thereby partici-
pating in events such as transcrip-
tion, splicing, and translation (Rocak 
and Linder 2004). Phosphorylation 
of p68 is prevalent in many cancer-
cell lines but not in normal tissues 
(Yang et al., 2005), implying that the 
regulation of p68 by phosphorylation 
may participate in growth control. 
Indeed, in HT-29 colon cancer cells, vier Inc.PDGF induces rapid phosphoryla-
tion of p68 on tyrosine 593 by the 
c-Abl kinase, which associates with 
p68 upon PDGF signaling (Yang et 
al., 2006b; Figure 1).
PDGF induces EMT in HT-29 colon 
cancer cells, as determined by loss 
of epithelial cell-cell contacts and 
cell scattering, and by loss of E-
cadherin and gain of vimentin and 
fibronectin expression (Yang et al., 
2006b). Depletion of p68 using small 
interfering RNAs (siRNAs) prevented 
EMT, which was rescued by reintro-
duction of p68 but not by introduc-
tion of a p68 mutant in which tyrosine 
593 was replaced with phenylalanine 
(Y593F). Importantly, when delivered 
into cells as recombinant proteins, 
p68 that had been phosphorylated 
by c-Abl in vitro, but neither unphos-
phorylated p68 nor p68(Y593F), was 
sufficient to induce EMT (Yang et al., 
2006b). Thus, phosphorylation of 
p68 on tyrosine 593 is necessary and 
sufficient for PDGF-induced EMT.
β-catenin plays two critical roles 
in cells: it regulates cell adhesion 
through association with E-cadherin 
at the plasma membrane, and it also 
activates transcription in the nucleus 
in response to Wnt signaling. There-Figure 1. The c-Abl-P68-β-Catenin Pathway
PDGF stimulation of epithelial cells activates c-Abl via tyrosine phosphorylation, which may be 
mediated by Src kinase (Yang et al., 2006b). This induces formation of the c-Abl-p68 complex, 
in which activated c-Abl phosphorylates p68 on tyrosine 593, which then dissociates from c-
Abl. Phosphorylated p68 binds to β-catenin, leading to (1) dissociation of GSK3 from Axin and 
inhibition of β-catenin phosphorylation and (2) dissociation of β-catenin from Axin. The ensuing 
nuclear accumulation of β-catenin, together with TCF-1, induces the transition of epithelial cells 
to mesenchymal cells (EMT). Note that p68 mutants that are defective in ATPase activity can bind 
to β-catenin and displace GSK3 from Axin, but can neither displace β-catenin from Axin nor elicit 
accumulation of β-catenin in the nucleus. See text for discussion on where in the cell each step 
of this pathway may occur. Phosphorylated p68 may activate additional targets to induce EMT. 
Other components of the Axin complex, such as CK1 and APC, are not shown.
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EMT (Brembeck et al., 2006). Yang 
et al. (2006b) found that p68 phos-
phorylated on tyrosine 593 but not 
unphosphorylated p68, binds to 
β-catenin (Figure 1), and that the 
interaction was required for PDGF-
induced β-catenin nuclear localiza-
tion. In fact, the authors observed 
a temporal order of p68-complex 
formation upon PDGF induction: the 
p68-c-Abl complex and accompany-
ing p68 phosphorylation were fol-
lowed by the disappearance of the 
complex and the appearance of the 
p68-β-catenin association (Figure 
1). The nuclear β-catenin was not 
simply a consequence of E-cadherin 
downregulation during EMT, because 
phosphorylated p68 promoted β-cat-
enin nuclear localization regardless of 
whether E-cadherin was depleted or 
overexpressed (Yang et al., 2006b). 
How does phosphorylated p68 lead 
to nuclear localization of β-catenin?
We rewind briefly to review how 
Wnt activates nuclear β-catenin 
signaling. In the absence of Wnt, 
cytosolic β-catenin (not E-cadherin-
associated β-catenin) is recruited 
to a “destruction” complex that 
includes the scaffolding protein Axin, 
the tumor suppressor APC, and CK1 
and GSK3 kinases, which sequen-
tially phosphorylate β-catenin, thus 
triggering its degradation. (Note that 
although HT29 cells harbor a trun-
cated APC protein, β-catenin phos-
phorylation and degradation can still 
occur [Yang et al., 2006a]). Activation 
of the Wnt-signaling pathway inhibits 
GSK3 phosphorylation of β-catenin, 
probably by disrupting the Axin-
GSK3-β-catenin complex (Liu et al., 
2005), thereby resulting in β-catenin 
accumulation and its ensuing nuclear 
localization. β-catenin then acts as a 
coactivator for LEF/TCF transcription 
factors (Brembeck et al., 2006).
Yang et al. (2006b) provide evi-
dence suggesting that phospho-
rylated p68 promotes β-catenin 
nuclear accumulation via the regu-
lation of the Axin complex, but with 
some interesting twists. Phosphor-
ylated p68 inhibited β-catenin phos-
phorylation by GSK3 in vitro and in 
vivo. Experiments using monoclonal antibodies (mAbs) to block the p68-
β-catenin interaction suggested that 
phosphorylated p68 might inhibit 
β-catenin phosphorylation via bind-
ing to the β-catenin amino terminus, 
where GSK3-phosphorylation sites 
reside. This interpretation, however, 
requires caution due to technical 
caveats such as the efficiency of 
delivering different mAbs into cells. 
Yang et al. (2006b) realized that an 
additional mechanism must be at 
work. Given that p68 is an ATPase, 
the authors tested the effect of p68 
mutants that lack ATPase activity 
on β-catenin nuclear accumulation. 
These mutants failed to induce the 
translocation of β-catenin into the 
nucleus despite being able to bind to 
β-catenin. Subsequent experiments, 
both in vitro and in vivo, suggested 
two separable activities of phosphor-
ylated p68. This RNA helicase disso-
ciates GSK3 from the Axin complex 
in an ATPase-independent manner. 
It then further dissociates β-catenin 
from the Axin complex via its ATPase 
activity (Figure 1). Presumably, either 
of these two p68 activities is suffi-
cient to inhibit β-catenin phosphor-
ylation by GSK3, but the data argue 
that displacement of β-catenin from 
Axin is required for β-catenin accu-
mulation in the nucleus. This distinc-
tion is of interest, as it echoes the 
observation in Drosophila embryos 
that Axin has a key role in anchor-
ing β-catenin in the cytoplasm (Tol-
winski and Wieschaus 2001). Finally, 
Yang et al. (2006b) demonstrate that 
EMT induced by phosphorylated p68 
requires both nuclear β-catenin and 
the transcription factor TCF-1.
This study has uncovered a new 
EMT pathway from PDGF, via c-Abl 
and p68, to nuclear β-catenin. Given 
that EGF (which, like PDGF, signals 
via a receptor tyrosine kinase) and 
TGFβ (which signals via serine/thre-
onine kinase receptors) also induce 
p68 tyrosine phosphorylation and 
require p68 for EMT induction in cul-
tured kidney epithelial cells (Yang et 
al., 2006b), the p68-β-catenin axis 
may represent a common output for 
several signaling pathways. These 
pathways offer additional routes to 
nuclear β-catenin signaling that are parallel to the Wnt pathway, which 
does not involve p68 (Yang et al., 
2006b). Other routes to β-catenin 
nuclear accumulation also exist. For 
example, phosphorylation of β-cat-
enin at tyrosine 142 by Met (also a 
receptor tyrosine kinase), Fer, or Fyn 
kinase diminishes β-catenin affinity 
for α-catenin in the E-cadherin com-
plex but enhances β-catenin bind-
ing to the transcriptional coactivator 
Bcl9-2, thereby leading to increased 
nuclear β-catenin signaling and EMT 
(Brembeck et al., 2006). It remains 
unclear whether these pathways 
operate independently or in concert.
Where and how p68 acts to 
elicit nuclear β-catenin localization 
deserves further investigation. p68 is 
predominantly a nuclear protein, and 
formation of the p68-c-Abl complex 
and subsequent p68 phosphoryla-
tion at tyrosine 593 was observed 
in the nucleus (Yang et al., 2006b). 
Given that it is generally believed 
that β-catenin phosphorylation and 
degradation by the Axin-GSK3 com-
plex occurs in the cytoplasm, and 
that some p68 could be detected 
in the cytosolic fraction upon PDGF 
treatment, the authors propose that 
phosphorylated p68 exits from the 
nucleus and acts in the cytoplasm 
to displace β-catenin from the Axin 
complex (Yang et al., 2006b). But 
other scenarios remain possible. 
For example, phosphorylated p68 
may act in the nucleus (1) as a β-
catenin retention partner and (2) 
to prevent export of β-catenin into 
the cytoplasm by Axin and/or APC 
(Bienz 2002; Cong and Varmus, 
2004). Indeed, some studies have 
suggested that cytoplasmic versus 
nuclear retention plays a major role in 
β-catenin localization (e.g., Tolwinski 
and Wieschaus 2001; Krieghoff et al., 
2006). Notably, there are remarkable 
similarities between phosphorylated 
p68 and Bcl9-2 in β-catenin bind-
ing and nuclear localization, and in 
the induction of EMT (Brembeck et 
al., 2006). Does Bcl9-2 also regulate 
the Axin-β-catenin complex directly? 
Can p68, like Bcl9-2, act as a β-cat-
enin coactivator?
How p68, an RNA-dependent 
ATPase, is regulated remains unknown 
(Rocak and Linder 2004). If ATP 
hydrolysis by p68 is required for dis-
placement of β-catenin from Axin as 
suggested but yet to be demonstrated 
by Yang et al. (2006b), is it possible 
that the Axin complex contains an 
RNA that activates p68 ATPase? Or 
is p68 a protein-dependent (more 
specifically, β-catenin-dependent) 
ATPase as well? Tyrosine 593 of p68 
is conserved in vertebrates (but not in 
invertebrates) and is located in the p68 
carboxyl terminus outside the globu-
lar catalytic core (Rocak and Linder 
2004). Does phosphorylation at this 
site regulate p68 catalytic function in 
addition to providing an interaction 
interface for β-catenin? Finally, as 
EMT has been implicated in cancer 42 Cell 127, October 6, 2006 ©2006 Else
Studies in many different areas of 
cancer research including epidemio-
logical studies have established the 
connection between inflammation and 
cancer (Balkwill et al., 2005; Balkwill 
and Mantovani, 2001; Coussens and 
Werb, 2002). For example, inflamma-
tory bowel disease is a risk factor for 
the development of colorectal cancer. 
Moreover, the usage of nonsteroid 
anti-inflammatory agents is associ-
ated with protection against various 
RalB signaling
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A connection between the ge
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(2006) show that the RalB GT
unexpected link between the 
In tumor cells the RalB/TBK1
stimulates an innate immune rinvasion (Thiery and Sleeman 2006), 
inhibitors of the c-Abl-p68-β-catenin 
pathway may be beneficial in prevent-
ing metastasis of tumor cells. In this 
regard, it is worth considering whether 
STI571/Gleevac—which inhibits c-Abl 
(and PDGF) signaling and is a potent 
anti-cancer drug for certain blood and 
solid tumors—may act in part by inhib-
iting the p68-β-catenin pathway and 
whether Gleevec may exhibit efficacy 
in preventing metastasis of other can-
cer types.
ReFeReNCes
Bienz, M. (2002). Nat. Rev. Mol. Cell Biol. 3, 
328–338.
Brembeck, F.H., Rosario, M., and Birchmeier, 
W. (2006). Curr. Opin. Genet. Dev. 16, 51–59.vier Inc.
tumors, and these drugs have been 
investigated as possible anticancer 
agents. Even tumors where a firm con-
nection to inflammation has not been 
established, such as breast cancer, 
exhibit an inflammatory microenviron-
ment at the site of the tumor. Indeed, 
an inflammatory component is present 
in the microenvironment of most neo-
plastic tissues. In this context, Chien 
et al. (2006) now identify a signaling 
pathway mediated by the RalB GTPase 
: A Bridge bet
nd Cancer
will1,2,*
, 20089 Rozzano and University of Milan, I
nd The London Queen Mary’s Medical Sch
netic events that lead to tumo
e response has been establis
Pase regulates the IKK family
signaling pathways that prom
 pathway inhibits apoptosis a
esponse.Cong, F., and Varmus, H.E. (2004). Proc. Natl. 
Acad. Sci. USA 101, 2882–2887.
Krieghoff, E., Behrens, J., and Mayr, B. (2006). 
J. Cell Sci. 119, 1453–1463.
Liu, X., Rubin, J.S., and Kimmel, A.R. (2005). 
Curr. Biol. 15, 1989–1997.
Rocak, S., and Linder, P. (2004). Nat. Rev. Mol. 
Cell Biol. 5, 232–241.
Thiery, J.P., and Sleeman, J.P. (2006). Nat. 
Rev. Mol. Cell Biol. 7, 131–142.
Tolwinski, N.S., and Wieschaus, E. (2001). De-
velopment 128, 2107–2117.
Yang, J., Zhang, W., Evans, P.M., Chen, X., 
He, X., and Liu, C. (2006a). J. Biol. Chem. 281, 
17751–17757.
Yang, L., Lin, C., and Liu, Z.R. (2005). Mol. 
Cancer Res. 3, 355–363.
Yang, L., Lin, C., and Liu, Z.R. (2006b). Cell, 
this issue.that regulates both tumor survival and 
the inflammatory response.
Many of the inflammatory factors 
that promote tumorigenesis are gen-
erated by cells in the tumor microen-
viroment, and not by the cancer cells 
themselves (called the “extrinsic” 
pathway in Figure 1)  (Balkwill et al., 
2005; Balkwill and Mantovani, 2001; 
Coussens and Werb, 2002). Inflam-
mation associated with tumors is char-
acterized by the infiltration of white 
ween 
taly
ool, London EC1M 6BQ, UK
r formation and the signaling 
hed. In this issue, Chien et al. 
 member TBK1, providing an 
ote inflammation and cancer. 
nd in nontumorigenic cells it 
